Successfully Co-Launching a Novel CDx & Oncology Treatment to Enable Patient Access to Life-Changing Therapies
- Best practice examples of launching novel CDx and oncology therapies to ensure streamlined market access
- Considering the challenges and priorities of simultaneously commercialising CDx and precision therapies